Patterns of thromboembolic pulmonary vascular disease in COVID-19

SARS-CoV-2 (COVID-19) is associated with increased thrombosis. Here, we demonstrate patterns of pulmonary vascular disease in COVID-19 including classical acute pulmonary embolism and subsegmental perfusion defects in the absence of acute pulmonary embolism suggestive of microvascular thrombosis.

Automated summary

SARS-CoV-2 (COVID-19) is associated with increased thrombosis, leading to patterns of pulmonary vascular disease including classical acute pulmonary embolism and microvascular thrombosis evident in subsegmental perfusion defects.